semaj83/ctmatch_classification huggingface dataset:
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Human Papillomavirus Premenopausal women with HSIL at Pap test or high-risk HPV  Suspicious cancer
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Female Genital Warts women aged 18 to 45 years, who had a Pap-smear in the preceding 90 days or were diagnosed with genital warts during physical examination good health  women self reported HIV-positive women undergoing antiretro-viral treatment illiteracy pregnancy
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 12.0-999.0,  Cystic Fibrosis Male or female with confirmed diagnosis of CF Must have the F508del-CFTR gene mutation in both alleles (Groups 1, 2, 3, 4, 5, 6). Group 7 participants must have the F508del-CFTR mutation on 1 allele, and gating mutation G551D on the second allele and have been on their physician prescribed 150 mg KalydecoTM q12h (commercially available ivacaftor) for at least 28 days at the Screening Visit Forced expiratory volume in 1 second(FEV1) 40% to 90% (inclusive) of predicted normal for age, gender, and height (Knudson standards) at screening Weight >40 kg and BMI >18.5 Participants of child-bearing potential and who are sexually active must meet the contraception requirements  History of any illness that, in the opinion of the investigator, might confound the results of the study or pose an additional risk in administering study drug to the participant An acute upper or lower respiratory infection, pulmonary exacerbation, or changes in therapy (including antibiotics) for pulmonary disease within 4 weeks before Study Day 1 History of solid organ or hematological transplantation Participation in a clinical study involving administration of either an investigational or a marketed drug within 30 days or 5 terminal half-lives (whichever is longer) before screening History of alcohol, medication, or illicit drug abuse within 1 year prior to screening Pregnant, breast-feeding, or not willing to follow contraception requirements
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  CIN2/3 Recurrence Women over 18 years CIN 2 or 3 diagnosis at confirmed for a CIN3 diagnosis by conization HPV detected by Hybrid Capture 2 or RLA genotyping Informed and signed consent by the patient and the investigator Coverage by French social security  Pregnancy at the time of inclusion Previous history conization Atypical endometrial or glandular cells or evidence of carcinoma on conization Previous vaccination with a prophylactic HPV vaccine Active viral infections including HIV Acquired or congenital immunodeficiency Long term treatment by corticosteroids or immunosuppressive drugs Persons under protection of law Patients unable to meet the requirements of the protocol Any condition that, according to the investigator, would prevent participation in the study or interfere with the objectives of the study (refusal of supervision at the University Hospital, expected change of address within 3 years, etc)
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 45.0-65.0,  Menopause Women without menstrual cycles within the last 12 months and FSH > 30IU/L Healthy women Women that were not using drugs with potential vascular effect within the last 1 year Women that never used hormone replacement therapy  Smoking Blood Pressure > 160/90 mm Hg Breast and or endometrial cancer History of acute myocardial infarction Diabetes Vaginal bleeding of any origin Hepatic disease Thrombophlebitis or thromboembolic disorders
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 16.0-26.0,  Cervical Cancer Cervical Intraepithelial Neoplasia Adenocarcinoma in Situ Healthy Japanese females Not pregnant at Screening and agree to use effective contraception through Month 7 of the study Lifetime history of 0 to 4 male or female sexual partners No oral temperature ≥37.5 centigrade within 24 hours prior to injection  Received a marketed HPV vaccine Prior abnormal Papanicolaou smear (PAP) or biopsy showing CIN Known history of positive test for HPV Known history of genital warts Received immune globulin or blood products within 6 months prior to first injection or plan to receive any through Month 7 of the study History of splenectomy, known immune disorders, or receiving immunosuppressives Immunocompromised or diagnosed as having human immunodeficiency virus (HIV)
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 21.0-999.0,  Atypical Squamous Cell of Undetermined Significance Cervical Carcinoma Cervical Intraepithelial Neoplasia Grade 2/3 Health Status Unknown Human Papillomavirus Infection Low Grade Cervical Squamous Intraepithelial Neoplasia Stage 0 Cervical Cancer Able to provide informed consent in English  Have had hysterectomy Currently pregnant Received treatment of cervical dysplasia with LEEP, cone biopsy, laser procedure or cryotherapy within THREE years Received colposcopy of cervix within TWO years Received Pap test within ONE year Immunocompromised (positive human immunodeficiency virus [HIV] test, transplant recipient, received chemotherapy for cancer, or taking immunosuppressant drugs) Decisionally impaired adults requiring a legally authorized representative
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Uterine Cervical Neoplasms women 18 years old or older have recently received an abnormal Pap smear indicative of oncogenic HPV have been referred for initial colposcopic evaluation at the Women's Care Center at Temple University Hospital able to communicate with ease in English  unable to communicate readily in English do not have access to a telephone have a history of any malignancy display current evidence of positive invasive carcinoma of the cervix display presence of another life-threatening medical condition show evidence of dementia prior participation in research study HIV
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 30.0-45.0,  HPV Infection pathologic Pap smear positive "high risk" HPV DNA test positive colposcopy examination  patients who had undergone wart therapy in the previous six months pregnancy invasive disease immunosuppression previous HPV vaccination
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 25.0-70.0,  Cervical Cancer Somali female age 25-70 years have lived in the U.S. 10 years or less have not had a Pap test (by self report) in the last 3 years  Women with a self reported past history of any of the following will not be eligible total hysterectomy cervical cancer active history of cervical dysplasia
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-40.0,  Behavioral Risk for HIV married female aged 18-40 years 2. fluency in Hindi or Marathi 3. residence with husband in the area of study for a period of 2 months or greater 4. reports that husband engaged in either heavy drinking past 30 day drunken behavior, or frequent drinking drinking days in past 7 days, or lifetime spousal violence perpetration 5. no plans to relocate from the area in the next year  cognitive impairment indicated at recruitment
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 30.0-65.0,  Human Papillomavirus Vaginal Infection female age over 30 PAP Test with FOR OR result HPV DNA Index Test with result after conization for 6 months not pregnant  cervical intraepithelial neoplasia before conization cervical cancer patient with GI surgery GI dysfunction need for long-term antibiotics treatment
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Oral Cancer You attend the Dental Department at the British Columbia Cancer Agency You have an abnormal lesion in the mouth You fully understand the study and give your informed consent to participate as demonstrated by signing this consent form  You are under the age of 18 years
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 50.0-70.0,  Periprosthetic Bone Loss in Total Knee Replacement severe knee osteoarthritis post menopausal women  immune disease end stage of renal disease who receive dialysis history of fracture at ipsilateral distal femur
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Teratogenesis Age of participants: 18-45 years old 2. Gender of participants: Female 3. Ethnic Background: No limitation, will minorities and Spanish speaking participants 4. Health Status: no limitation 5. Sexually active with men  Currently Pregnant 2. Not sexually active with men 3. History of hysterectomy 4. Removal of both ovaries
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 9.0-999.0,  Tooth; Lesion, White Spot Lesions Two early caries lesion in the same patient, lesion with the same radiolucencies images  Pregnancy, use of orthodontics appliences, use of drugs modified salivar flow, ausence of adjacent teeth
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Uterine Cervical Neoplasms Referred to follow up due to one or more abnormal Pap or an HPV infection Subjects who have provided informed consent Subjects who meet the minimum age set forth by the ethics committee (EC) and/or national screening guidelines  Known to be pregnant With prior complete or partial hysterectomy involving removal of cervix Subjects with an application of chemical compounds to the cervical area 24 hour prior to study entry this includes acetic acid, iodine, spermicide, douche, anti-fungal meds Subjects on who conization, Loop electrosurgical excision procedure (LEEP), laser surgery or cryosurgery has been performed
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Cervical Intraepithelial Neoplasia Women 18-65 years of age Not menstruating (if menstruating, the patient can be screened at another date) Able to sign consent Able to follow the study protocol HIV positive (by two different criteria; either 2 different rapid HPV tests of different manufacturers, a HIV viral load ≥5,000,ELISA, Western blot documented in VICAR 1) Participant with histology-proven CIN 2 or 3 disease  Pregnant Clinically active sexually transmitted disease determined by clinical history and/or physical exam (may participate after adequate treatment by syndromic treatment management) Known and previous treatment for high grade squamouse intraepithelial lesion by any method (cryotherapy, LLETZ or cone biopsy) Previous hysterectomy with removal of the cervix Significant medical illness/mental illness that the investigator feels would prevent the participant from complying with the protocol or place the participant at medical risk Cervical dysplastic lesions that are not appropriate for cryotherapy, defined as the following: 1. Lesion is greater than ≥75% cervix 2. Lesion entering into the cervical canal and the complete lesion cannot be visualized 3. Presence of abnormal vasculature 4. Lesion bigger that the cryotherapy probe
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Intimate Partner Violence She is 18 or older She is currently court supervision at Bronx Community Solutions or a drug treatment court or she is currently on probation She reports using any illicit drug or drinking 4 or more alcoholic drinks in a 6-hour period in the past 90 days or she has been in alcohol or drug treatment in the past 6 months OR if she report attending any drug or alcohol treatment in the past 6 months She reports having had an ongoing intimate, dating or sexual relationship with a male or female partner that lasted 3 or more months in the past year She lives within a 90-minute commute of 125th and Broadway  Ability to speak and understand English is not sufficient to participate in assessments or intervention sessions Inability to complete informed consent process due to a psychiatric or cognitive impairment The participant is unwilling or unable to commit to completing all the activities in the study
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Cancer HIV infected women, older than 18 years of age, followed in the PHPT cohort  Virginity, total hysterectomy, pregnancy after 3rd month, in a HPV vaccination trial
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 30.0-65.0,  HPV Infection Age 30 to 65 years of age the sex life of female patients; 2. , liquid-based cytology (TCT) check no intraepithelial lesions and malignant cells; 3. , HPV DNA typing test for high-risk HPV positive (including a single high-risk type positive, and more high-risk type of positive and high-and low-risk hybrid positive). 15 kinds of high-risk types, including HPV16, 18,31,33,35,39,45,51,52,53,56,58,59,66,68  (1) cervical intraepithelial neoplasia (CIN); (2), combined with a severe fungal, trichomonas vaginitis; (3), severe primary diseases associated with cardiovascular, liver, kidney and hematopoietic system; (4), allergies or allergy to the drug known ingredients. (5), within 30 days to accept other clinical trials of drugs or are participating in clinical trials; (6), pregnant and lactating women and to be pregnant women; (7), the researchers do not consider it appropriate clinical trials
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Dysplasia Cervical Cancer Female ages 18 years or older English speaking Presenting for pap smear examination  Pregnancy
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-85.0,  Anal Squamous Intraepithelial Lesion (ASIL) HPV DNA All IBD patients followed in the IBD clinic and healthy controls who are greater than 18 years old  History of HPV vaccination Pregnancy Other immunosuppressed states (i.e. systemic lupus erythematosus, rheumatoid arthritis, cancer, Human Immunodeficiency Virus (HIV), transplant) IBD patients who don't meet immunosuppression/non-immunosuppression Inability to obtain informed consent from patient Previous diagnosis of ASIL or anal/rectal cancer
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  HIV Infection She is at least 18 years of age She reports having engaged in vaginal or anal sexual intercourse in the past 90 days in exchange for money, alcohol or other goods She reports having engaged in unprotected vaginal or anal sexual intercourse in the past 90 days with a paying sexual partner; and She reports being interested in learning about and developing her own small business  assessed to have a severe cognitive or psychiatric impairment that would interfere with the ability to provide informed consent or complete study instruments